Analogic Corporation (NASDAQ:ALOG) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure |
Attached as Exhibit 99.1, and furnished for purposes of
Regulation FD, is an investor presentation to be given by
Analogic Corporation at the Jefferies 2017 Healthcare Conference
to be held on June8, 2017.
The information in this Current Report on Form 8-K (including
Exhibit99.1) is being furnished to Item 7.01 and shall not be
deemed to be filed for purposes of Section18 of the Securities
Exchange Act of 1934 (the Exchange Act) or otherwise subject to
the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act
of 1933 or the Exchange Act. The information set forth in this
Item 7.01 shall not be deemed an admission as to the materiality
of any information in this Current Report on Form 8-K that is
required to be disclosed solely to satisfy the requirements of
Regulation FD.
| Item9.01 | Financial Statements and Exhibits |
| (d) | The following exhibit is furnished, and not filed: |
| Exhibit No. | Description | |
| 99.1 | Analogic Corporation Investor Presentation |
About Analogic Corporation (NASDAQ:ALOG)
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.